Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients

NCT01435174 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01435174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01435174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Lead sponsor
University of Michigan
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
March 31, 2013
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, end-stage renal disease